Literature DB >> 1435787

Alanine-scanning mutagenesis of human prolactin: importance of the 58-74 region for bioactivity.

V Goffin1, M Norman, J A Martial.   

Abstract

We have generated 10 alanine mutants of human PRL (hPRL), a member of the PRL/GH family, to investigate the involvement of the highly conserved 58-74 region in the biological behavior of the protein. When treated with polyclonal anti-hPRL antibodies, all mutants were immunologically indistinguishable from the unmodified hPRL, and circular dichroism analyses indicated that their alpha-helix content was similar to that of the unmodified hormone. Mutations C58A, K69A, and, to a lesser extent, P66A affected drastically the ability of hPRL first to bind to the lactogenic receptor and second to stimulate the proliferation of Nb2 lymphoma cells, proving the importance of the 58-74 peptide segment for hPRL bioactivity. Binding affinities of these mutants to the Nb2 lactogenic receptor have been compared to lactogenic binding data previously obtained for several mutants of hGH. The comparison reveals that the residues involved in the biological properties of the two proteins are not at topologically equivalent positions. Hence, we suggest that the binding of these hormones to the lactogenic receptors occurs through a different molecular mechanism having distinct requirements at the residue level.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1435787     DOI: 10.1210/mend.6.9.1435787

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  9 in total

Review 1.  Activating mechanism of CNTF and related cytokines.

Authors:  M Inoue; C Nakayama; H Noguchi
Journal:  Mol Neurobiol       Date:  1996-06       Impact factor: 5.590

2.  Inhibitory activity of the peptides derived from buffalo prolactin on angiogenesis.

Authors:  Jaeok Lee; Syamantak Majumder; Suvro Chatterjee; Kambadur Muralidhar
Journal:  J Biosci       Date:  2011-06       Impact factor: 1.826

3.  Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation.

Authors:  Mandar V Kulkarni; M Cristina Tettamanzi; James W Murphy; Camille Keeler; David G Myszka; Naomi E Chayen; Elias J Lolis; Michael E Hodsdon
Journal:  J Biol Chem       Date:  2010-09-30       Impact factor: 5.157

4.  New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity.

Authors:  Sophie Bernichtein; Sébastien Jeay; Roland Vaudry; Paul A Kelly; Vincent Goffin
Journal:  Endocrine       Date:  2003 Feb-Mar       Impact factor: 3.633

5.  Two wrongs can make a right: dimers of prolactin and growth hormone receptor antagonists behave as agonists.

Authors:  John F Langenheim; Dunyong Tan; Ameae M Walker; Wen Y Chen
Journal:  Mol Endocrinol       Date:  2005-11-03

6.  Molecular evolution of prolactin in primates.

Authors:  O Caryl Wallis; Akofa O Mac-Kwashie; Georgia Makri; Michael Wallis
Journal:  J Mol Evol       Date:  2005-05       Impact factor: 2.395

7.  Crystal structure of an affinity-matured prolactin complexed to its dimerized receptor reveals the topology of hormone binding site 2.

Authors:  Isabelle Broutin; Jean-Baptiste Jomain; Estelle Tallet; Jan van Agthoven; Bertrand Raynal; Sylviane Hoos; Birthe B Kragelund; Paul A Kelly; Arnaud Ducruix; Patrick England; Vincent Goffin
Journal:  J Biol Chem       Date:  2010-01-06       Impact factor: 5.157

8.  Investigation of prolactin receptor activation and blockade using time-resolved fluorescence resonance energy transfer.

Authors:  Estelle Tallet; Isabelle Fernandez; Chi Zhang; Marion Salsac; Nathalie Gregor; Mohammed Akli Ayoub; Jean Philippe Pin; Eric Trinquet; Vincent Goffin
Journal:  Front Endocrinol (Lausanne)       Date:  2011-09-16       Impact factor: 5.555

9.  Prolactin decreases LPS-induced inflammatory cytokines by inhibiting TLR-4/NFκB signaling in the human placenta.

Authors:  A Olmos-Ortiz; M Déciga-García; E Preciado-Martínez; L Bermejo-Martínez; P Flores-Espinosa; I Mancilla-Herrera; C Irles; A C Helguera-Repetto; B Quesada-Reyna; V Goffin; L Díaz; V Zaga-Clavellina
Journal:  Mol Hum Reprod       Date:  2019-10-28       Impact factor: 4.025

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.